Ganymed Pharmaceuticals

Developer of antibody-based drugs for the treatment of solid cancers

placeMainz, Rhineland-Palatinate, Germany calendar_todayFounded 2001 groups4 employees language ganymed-pharmaceuticals.com

Registered entities

Investor mix

10 investors on record; 1 has since exited.

Investor typeCountShare
Venture capital660%
Private equity110%
Other / undisclosed330%
Coming soon